7584-08-9 Usage
Uses
Used in Pharmaceutical Industry:
3,5-Dimethylisonicotonitrile is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 3,5-Dimethylisonicotonitrile is utilized as a precursor for the production of various agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Organic Synthesis:
3,5-Dimethylisonicotonitrile is employed as a valuable building block in organic synthesis, enabling the creation of a wide range of chemical compounds for diverse applications.
Used in Heterocyclic Compound Synthesis:
As an important reagent, 3,5-Dimethylisonicotonitrile is used in the synthesis of heterocyclic compounds, which are significant in various fields such as medicine, materials science, and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 7584-08-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,8 and 4 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7584-08:
(6*7)+(5*5)+(4*8)+(3*4)+(2*0)+(1*8)=119
119 % 10 = 9
So 7584-08-9 is a valid CAS Registry Number.
InChI:InChI=1S/C8H8N2/c1-6-4-10-5-7(2)8(6)3-9/h4-5H,1-2H3
7584-08-9Relevant academic research and scientific papers
Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: Synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides
Palani, Anandan,Shapiro, Sherry,Clader, John W.,Greenlee, William J.,Vice, Susan,McCombie, Stuart,Cox, Kathleen,Strizki, Julie,Baroudy, Bahige M.
, p. 709 - 712 (2007/10/03)
The synthesis, SAR and biological evaluation of symmetrical amide analogues of our clinical candidate SCH 351125 are described. A series of potent and orally bioavailable CCR5 antagonists containing symmetrical 2,6-dimethyl isonicotinamides and 2, 6-dimethyl pyrimidines amides were generated with enhanced affinity for the CCR5 receptor.
